• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov15
SAB Biotherapeutics released FY2025 9 Months Earnings on November 14 (EST), Actual Revenue USD 0, Actual EPS USD -0.0228
04:00
SAB Biotherapeutics released FY2025 Q3 earnings on November 14 (EST), actual revenue USD 0 (forecast USD 83.33K), actual EPS USD -0.2126 (forecast USD -0.4583)
04:00
Oct22
Smith Analyst Covers Multiple Healthcare Stocks and Gives Strong Buy Rating to SAB Biotherapeutics
10:21
Oct18
Smith focuses on specific healthcare stocks
12:56
Aug8
SAB Biotherapeutics released FY2025 Semi-Annual earnings on August 7 (EST), actual revenue USD 0, actual EPS USD 0.1903
03:00
SAB Biotherapeutics released FY2025 Q2 earnings on August 7, 2025 (EST), actual revenue USD 0 (forecast USD 100K), actual EPS USD 0.749 (forecast USD -0.796)
03:00

Schedules & Filings

Schedules
Filings
Nov14
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Net Income 5.338 M, EPS -0.2126

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Net Income 6.966 M, EPS 0.749

May9
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Net Income -5.197 M, EPS -0.5592

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
TGL
25.440
+276.44%
+18.682
SMX
331.980
+135.45%
+190.980
WHLR
6.410
+97.84%
+3.170
DBRG
14.120
+45.27%
+4.400
TORO
5.800
+40.44%
+1.670
TDIC
0.3937
+40.21%
+0.113
LICN
4.070
+38.91%
+1.140
SPHL
4.530
+36.04%
+1.200
ALMS
11.120
+33.98%
+2.820
WAI
3.360
+32.28%
+0.820
View More